
    
      A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy
      and Safety of Saxagliptin (BMS-477118) in Combination with Metformin IR or Metformin XR in
      Pediatric Patients with Type 2 Diabetes who have Inadequate Glycemic Control on Metformin
      Alone or in Combination with Baseline Insulin Therapy
    
  